Please help to analyse the below vertical analysis.

Statement of
Profit or Loss and Other Comprehensive Income
DUOPHARMA BIOTECH BERHAD
DUOPHARMA BIOTECH BERHAD
	2016		2017		2018		2019		2020
	RM'000	%	RM'000	%	RM'000	%	RM'000	%	RM'000	%
Revenue	312,940	100%	467,987	100%	498,722	100%	576,462	100%	569,902	100%
Cost of sales	- 168,808	-53.94%	- 281,100	-60.07%	- 294,242	-59.00%	- 344,395	-59.74%	- 336,701	-59.08%
Gross profit	144,132	46.06%	186,887	39.93%	204,480	41.00%	232,067	40.26%	233,201	40.92%
Other Income	818	0.26%	500	0.11%	1,083	0.22%	1,242	0.22%	648	0.11%
Distribution and marketing expenses	- 64,887	-20.73%	- 78,479	-16.77%	- 75,655	-15.17%	- 85,818	-14.89%	- 81,159	-14.24%
Administrative expenses	- 44,409	-14.19%	- 50,195	-10.73%	- 61,327	-12.30%	- 69,534	-12.06%	- 69,655	-12.22%
Net gain/(loss) on impairment of financial instruments	-	0%	-	0.00%	- 845	-0.17%	412	0.07%	820	0.14%
Other expenses	- 2,859	-0.91%	- 4,390	-0.94%	- 2,452	-0.49%	- 724	-0.13%	- 1,999	-0.35%
Results from operating activities	32,795	10.48%	54,323	11.61%	65,284	13.09%	77,645	13.47%	81,856	14.36%
Finance income	4,234	1.35%	2,718	0.58%	2,111	0.42%	1,463	0.25%	1,510	0.26%
Finance costs	- 5,550	-1.77%	- 5,269	-1.13%	- 7,729	-1.55%	- 8,299	-1.44%	- 7,209	-1.26%
Profit before tax	31,479	10.06%	51,772	11.06%	59,666	11.96%	70,809	12.28%	76,157	13.36%
Tax expense	- 4,653	-1.49%	- 9,309	-1.99%	- 12,025	-2.41%	- 15,536	-2.70%	- 17,547	-3.08%
Profit for the year	26,826	8.57%	42,463	9.07%	47,641	9.55%	55,273	9.59%	58,610	10.28%
Net change in fair value of equity instruments designated at fair value through other comprehensive income	-	0.00%	-	0.00%	- 27,649	-5.54%	- 224	-0.04%	63,088	11.07%
Foreign currency translation differences for foreign operations	289	0.09%	1,018	0.22%	- 158	-0.03%	- 154	-0.03%	- 396	-0.07%
Total comprehensive income for the year	27,115	8.66%	43,481	9.29%	19,834	3.98%	54,895	9.52%	121,302	21.28%
Statement of
Profit or Loss and Other Comprehensive Income
Pharmaniaga Berhad
Pharmaniaga Berhad
	2016		2017		2018		2019		2020
	RM'000	%	RM'000	%	RM'000	%	RM'000	%	RM'000	%
Revenue	2,189,022	100%	2,323,960	100%	2,384,956	100%	2,820,530	100%	2,725,071	100%
Cost of sales	- 1,845,775	-84.32%	-1,988,798	-85.58%	- 2,062,845	-86.49%	- 2,726,549	-96.67%	-2,429,875	-89.17%
Gross profit	343,247	15.68%	335,162	14.42%	322,111	13.51%	93,981	3.33%	295,196	10.83%
Other Income	1,312	0.06%	9,006	0.39%	959	0.04%	1,245	0.04%	1,276	0.05%
Administrative expenses	-239,877	-10.96%	-243,057	-10.46%	- 217,677	-9.13%	- 248,225	-8.80%	- 227,610	-8.35%
Finance costs	-33,703	-1.54%	-28,774	-1.24%	- 36,072	-1.51%	- 40,258	-1.43%	- 33,702	-1.24%
Interest income	1,038	0.05%	727	0.03%	899	0.04%	1,392	0.05%	633	0.02%
Profit before zakat and taxation	72,017	3.29%	73,064	3.14%	70,220	2.94%	- 191,865	-6.80%	35,793	1.31%
Zakat	-250	-0.01%	-600	-0.03%	- 1,071	-0.04%	- 2,240	-0.08%	- 2,522	-0.09%
Taxation	-25,908	-1.18%	-17,377	-0.75%	- 25,919	-1.09%	44,658	1.58%	- 7,002	-0.26%
Net profit for the financial year	45,859	2.09%	55,087	2.37%	43,230	1.81%	-149,447	-5.30%	26,269	0.96%
Owners of the parent	45,599	2.08%	53,823	2.32%	42,468.00	1.78%	- 149,219	-5.29%	27,489	1.01%
Non-controlling interests	260	0.01%	1,264	0.05%	762.00	0.03%	- 228	-0.01%	- 1,220	-0.04%
Net profit for the financial year	45,859	2.09%	55,087	2.37%	43,230	1.81%	- 149,447	-5.30%	26,269	0.96%
Foreign currency translation differences for foreign operations	9,137	0.42%	- 16,900	-0.73%	- 2,670	-0.11%	2,544	0.09%	- 3,248	-0.12%
Recognition of actuarial losses	- 74	0.00%	- 224	-0.01%	679	0.03%	- 212	-0.01%	295	0.01%
Other comprehensive (loss)/income, net of tax for the financial year	9,063	0.41%	- 17,124	-0.74%	- 1,991	-0.08%	2,332	0.08%	- 2,953	-0.11%
Total comprehensive income, net of tax for the financial year	54,922	2.51%	37,963	1.63%	41,239	1.73%	- 147,115	-5.22%	23,316	0.86%
Owners of the parent	53,009	2.42%	41,627	1.79%	40,750	1.71%	- 147,122	-5.22%	24,868	0.91%
Non-controlling interests	1,913	0.09%	- 3,664	-0.16%	489	0.02%	7	0.00%	- 1,552	-0.06%
	54,922	2.51%	37,963	1.63%	41,239	1.73%	- 147,115	-5.22%	23,316	0.86%